The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Activation of Sirt1 Decreases Adipocyte Formation During Osteoblast Differentiation of Mesenchymal Stem Cells
Open accessAbstract
In vitro, mesenchymal stem cells differentiate to osteoblasts when exposed to bone-inducing medium. However, adipocytes are also formed. We showed that activation of the nuclear protein deacetylase Sirt1 reduces adipocyte formation and promotes osteoblast differentiation. Introduction: Mesenchymal stem cells (MSCs) can differentiate into osteoblasts, adipocytes, chondrocytes, and myoblasts. It has been suggested that a reciprocal relationship exists between the differentiation of MSCs into osteoblasts and adipocytes. Peroxisome proliferator-activated receptor γ2 (PPARγ2) is a key element for the differentiation into adipocytes. Activation of Sirt1 has recently been shown to decrease adipocyte development from preadipocytes through inhibition of PPARγ2. Materials and Methods: We used the mouse mesenchymal cell line C3H10T1/2 and primary rat bone marrow cells cultured in osteoblast differentiation medium with or without reagents affecting Sirt1 activity. Adipocyte levels were analyzed by light microscopy and flow cytometry (FACS) after staining with Oil red O and Nile red, respectively. Osteoblast and adipocyte markers were studied with quantitative real-time PCR. Mineralization in cultures of primary rat bone marrow stromal cells was studied by von Kossa and alizarin red staining. Results: We found that Sirt1 is expressed in the mesenchymal cell line C3H10T1/2. Treatment with the plant polyphenol resveratrol as well as isonicotinamide, both of which activate Sirt1, blocked adipocyte development and increased the expression of osteoblast markers. Nicotinamide, which inhibits Sirt1, increased adipocyte number and increased expression of adipocyte markers. Furthermore, activation of Sirt1 prevented the increase in adipocytes caused by the PPARγ-agonist troglitazone. Finally, activation of Sirt1 in rat primary bone marrow stromal cells increased expression of osteoblast markers and also mineralization. Conclusions: In this study, we targeted Sirt1 to control adipocyte development during differentiation of MSCs into osteoblasts. The finding that resveratrol and isonicotinamide markedly inhibited adipocyte and promoted osteoblast differentiation may be relevant in the search for new treatment regimens of osteoporosis but also important for the evolving field of cell-based tissue engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 2×
“Interestingly, transgenic mice expressing mutated p53 with increased activity exhibited, among other phenotypes, osteoporosis.((27))”
BackgroundPPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth
Rosen, E. D., & Spiegelman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100034200 · Cited by 1,175
Baksh, D., Song, L., & Tuan, R. S. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00320.x · Cited by 1,105
Gehm, B. D., McAndrews, J. M., Chien, P.-Y., & Jameson, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14138 · Cited by 1,063
PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U.-I., Kubota, N., Terauchi, Y., Harada, Y., Azuma, Y., Nakamura, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19900 · Cited by 869
MEUNIER, P., AARON, J., EDOUARD, C., & VlGNON, G. (1971) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197110000-00021 · Cited by 779
Stauffer, S. R., Coletta, C. J., Tedesco, R., Nishiguchi, G., Carlson, K., Sun, J., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000170m · Cited by 760
Meyers, M. J., Sun, J., Carlson, K. E., Marriner, G. A., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010254a · Cited by 678
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
Grigoriadis, A. E., Heersche, J. N., & Aubin, J. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.6.2139 · Cited by 649
Bone Is a Target for the Antidiabetic Compound Rosiglitazone
Rzonca, S. O., Suva, L. J., Gaddy, D., Montague, D. C., & Lecka-Czernik, B. (2004) · Endocrinology · doi:10.1210/en.2003-0746 · Cited by 454
Burkhardt, R., Kettner, G., Böhm, W., Schmidmeier, M., Schlag, R., Frisch, B., Mallmann, B., Eisenmenger, W., & Gilg, T. (1987) · Bone · doi:10.1016/8756-3282(87)90015-9 · Cited by 452
Lecka-Czernik, B., Moerman, E. J., Grant, D. F., Lehmann, J. M., Manolagas, S. C., & Jilka, R. L. (2002) · Endocrinology · doi:10.1210/endo.143.6.8834 · Cited by 441
Ren, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., & Camp, H. S. (2002) · Genes & Development · doi:10.1101/gad.953802 · Cited by 362
Bouras, T., Fu, M., Sauve, A. A., Wang, F., Quong, A. A., Perkins, N. D., Hay, R. T., Gu, W., & Pestell, R. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408748200 · Cited by 355
Nuttall, M. E., Patton, A. J., Olivera, D. L., Nadeau, D. P., & Gowen, M. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.371 · Cited by 354
PPARs: transcriptional effectors of fatty acids and their derivatives
Hihi, A. K., Michalik, L., & Wahli, W. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8467-x · Cited by 311
Knouff, C., & Auwerx, J. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0036 · Cited by 256
Rieusset, J., Touri, F., Michalik, L., Escher, P., Desvergne, B., Niesor, E., & Wahli, W. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0036 · Cited by 214
Diascro, D. D., Vogel, R. L., Johnson, T. E., Witherup, K. M., Pitzenberger, S. M., Rutledge, S. J., Prescott, D. J., Rodan, G. A., & Schmidt, A. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.96 · Cited by 210
Rosen, K., Coll, M. L., Li, A., & Filmus, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106424200 · Cited by 202
Interconversion potential of cloned human marrow adipocytes in vitro
Park, S. R., Oreffo, R. O. C., & Triffitt, J. T. (1999) · Bone · doi:10.1016/s8756-3282(99)00084-8 · Cited by 180
Porcu, M., & Chiarugi, A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.009 · Cited by 173
Chemical Activation of Sir2-Dependent Silencing by Relief of Nicotinamide Inhibition
Sauve, A. A., Moir, R. D., Schramm, V. L., & Willis, I. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.032 · Cited by 147
Thiazolidinediones Inhibit Osteoclast-Like Cell Formation and Bone Resorption in Vitro1
Okazaki, R., Toriumi, M., Fukumoto, S., Miyamoto, M., Fujita, T., TANAKA, K., & Takeuchi, Y. (1999) · Endocrinology · doi:10.1210/endo.140.11.7116 · Cited by 105
Duque, G., Macoritto, M. P., & Kremer, R. B. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.11.008 · Cited by 73
PPARγ activators down‐regulate the expression of PPARγ in 3T3‐L1 adipocytes
Camp, H. S., Whitton, A. L., & Tafuri, S. R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00268-9 · Cited by 57
Collas, P., & Håkelien, A.-M. (2003) · Trends in biotechnology · doi:10.1016/s0167-7799(03)00147-1 · Cited by 54
Johnson, T. E., Vogel, R., Rutledge, S. J., Rodan, G. A., & Schmidt, A. (1999) · Endocrinology · doi:10.1210/endo.140.7.6797 · Cited by 49
Cited by
Sirtuins in mammals: insights into their biological function
Michan, S., & Sinclair, D. (2007) · Biochemical Journal · doi:10.1042/bj20070140 · Cited by 1,718
Manolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules
Moseti, D., Regassa, A., & Kim, W.-K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010124 · Cited by 736
Adipokines as novel biomarkers and regulators of the metabolic syndrome
Deng, Y., & Scherer, P. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05875.x · Cited by 558
Muruganandan, S., Roman, A. A., & Sinal, C. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8429-z · Cited by 458
Metadata
- Authors
- Bäckesjö, C.-M., Li, Y., Lindgren, U., & Haldosén, L.-A.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-01
- Volume
- 21
- Issue
- 7
- Pages
- 993-1002
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1982863620
- Cited by
- 256
- References
- 31
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.